C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 39/395 (2006.01) C07H 21/00 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) C07K 19/00 (2006.01) C12N 9/12 (2006.01) C12N 15/62 (2006.01) C12Q 1/48 (2006.01) C12Q 1/68 (2006.01) G01N 33/566 (2006.01)
Patent
CA 2238007
The present invention relates to the cloning of .beta.APP-C100 receptor (C100- R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of .beta.-APP involved in Alzheimer's Disease.
L'invention concerne le clonage du récepteur de .beta.APP-C100 (C100-R), ainsi que des cellules hôtes mises au point par génie génétique et exprimant le C100-R. Lesdites cellules peuvent être utilisées pour évaluer et cribler des médicaments et des analogues de .beta.-APP impliquée dans la maladie d'Alzheimer.
Kozlowski Michael R.
Manly Susan P.
Neve Rachael L.
Bristol-Myers Squibb Company
Mclean Hospital Corporation
Osler Hoskin & Harcourt Llp
LandOfFree
Cloning and expression of .beta.app-c100 receptor (c100-r) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloning and expression of .beta.app-c100 receptor (c100-r), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning and expression of .beta.app-c100 receptor (c100-r) will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1971582